Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shelton Clinical Research Consultants appears to have been a small private clinical research consulting and contract research organization focused on supporting drug development and clinical trial operations rather than developing proprietary therapeutics. Publicly available evidence ties the business to owners and executives Antony Verco, MD, MBA and Shelagh Verco, both of whom have backgrounds in biotech and pharmaceutical clinical development. The company has been referenced in industry biographies as a prior consulting business owned by these executives, suggesting work in early-stage development, operational oversight, and related clinical research support. Available records indicate corporate registrations in California in the United States and in Alberta, Canada, but there is no evidence of an active drug pipeline, platform technology, public listing, or acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shelton Clinical Research Consultants.